Download PDF
J Neurol Surg B Skull Base 2022; 83(S 02): e459-e466
DOI: 10.1055/s-0041-1731031
Original Article

Prognosis of Distant Metastatic Sites in Anterior Skull Base Malignancies

Daniel O. Kraft
1   Warren Alpert Medical School, Brown University, Providence, Rhode Island, United States
,
Ryan M. Carey
2   Department of Otorhinolaryngology—Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
,
Aman Prasad
3   Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States
,
Karthik Rajasekaran
2   Department of Otorhinolaryngology—Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
,
Michael A. Kohanski
2   Department of Otorhinolaryngology—Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
,
David W. Kennedy
2   Department of Otorhinolaryngology—Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
,
James N. Palmer
2   Department of Otorhinolaryngology—Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
,
Nithin D. Adappa
2   Department of Otorhinolaryngology—Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
,
Jason G. Newman
2   Department of Otorhinolaryngology—Head and Neck Surgery, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, United States
,
Jason A. Brant
4   Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, United States
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Objective This study aimed to provide information regarding the prognosis of patients presenting with metastatic anterior skull base malignancies based upon histology and site of distant metastasis (DM).

Patients and Methods The National Cancer Database was queried for patients with anterior skull base malignant neoplasms with DM.

Outcomes Prognosis was compared between site of DM and tumor histologies. A multivariable Cox proportional hazards model was used to identify prognostic factors for overall survival (OS).

Results A total of 481 patients were identified. Lung was the most common site of DM (24.9%), followed by bone (22.2%), liver (5.6%), and brain (2.5%). Lung was the most common site for squamous cell carcinoma (SCCa) (28.3%), melanoma (37.7%), and adenoid cystic carcinoma (ACC; 31.4%). The median survival for patients presenting with metastatic disease regardless of tumor histology was 9.0 months (95% confidence interval [CI]: 8.2–10.3), and patients with metastasis to the liver had the best median survival at 15.5 months (95% CI: 10.5–25.6). The median survivals for the most common histologies, SCCa, melanoma, and ACC were 8.2 months (95% CI: 5.5–10.2), 10.5 months (95% CI: 8.7–14.1), and 15.0 months (95% CI: 11.1–61.1), respectively. Multivariable analysis demonstrated worse overall survival (OS) for older patients, higher Charlson-Deyo comorbidity scores, and tumors with higher grade and T stage. Compared with metastasis to bone, lung metastasis had better OS on multivariable analysis (hazard ratio [HR]: 0.70, 95% CI: 0.51–97). Adenoid cystic carcinoma had improved OS compared with SCCa (HR: 0.62, 95% CI: 0.39–99).

Conclusion Tumor histology, metastatic sites, and several disease factors affected prognosis in anterior skull base malignancies with DM.

Keywords

anterior skull base tumor - sinonasal malignancy - distant metastasis - primary tumor histology - survival


Publication History

Received: 02 February 2021

Accepted: 06 May 2021

Article published online:
10 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Lund VJ, Stammberger H, Nicolai P. et al; European Rhinologic Society Advisory Board on Endoscopic Techniques in the Management of Nose, Paranasal Sinus and Skull Base Tumours. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl 2010; 22 (22) 1-143
    PubMedGoogle Scholar
  • 2 Raghavan P, Phillips CD. Magnetic resonance imaging of sinonasal malignancies. Top Magn Reson Imaging 2007; 18 (04) 259-267
    CrossrefPubMedGoogle Scholar
  • 3 Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P, Bossi P, Locatelli D. Sinonasal malignancies of anterior skull base: histology-driven treatment strategies. Otolaryngol Clin North Am 2016; 49 (01) 183-200
    CrossrefPubMedGoogle Scholar
  • 4 Kim BJ, Kim DW, Kim SW. et al. Endoscopic versus traditional craniofacial resection for patients with sinonasal tumors involving the anterior skull base. Clin Exp Otorhinolaryngol 2008; 1 (03) 148-153
    CrossrefPubMedGoogle Scholar
  • 5 Ferrari M, Bossi P, Mattavelli D, Ardighieri L, Nicolai P. Management of sinonasal adenocarcinomas with anterior skull base extension. J Neurooncol 2020; 150 (03) 405-417
    CrossrefPubMedGoogle Scholar
  • 6 Suarez C, Llorente JL, Fernandez De Leon R, Maseda E, Lopez A. Prognostic factors in sinonasal tumors involving the anterior skull base. Head Neck 2004; 26 (02) 136-144
    CrossrefPubMedGoogle Scholar
  • 7 Winchester DP, Stewart AK, Phillips JL, Ward EE. The national cancer data base: past, present, and future. Ann Surg Oncol 2010; 17 (01) 4-7
    CrossrefPubMedGoogle Scholar
  • 8 Surgeons ACo.. National Cancer Database database online. https://www.facs.org/quality-programs/cancer/ncdb Accessed 2020
    PubMedGoogle Scholar
  • 9 Jack A, Percy C, Sobin L, Shanmugarathan S, Whelan S. International classification of diseases for oncology: ICD-O. World Health Organization; 2000
    Google Scholar
  • 10 Brand RA. Standards of reporting: the CONSORT, QUORUM, and STROBE guidelines. In: Accessed 2009 Springer; https://link.springer.com/article/10.1007/s11999-009-0786-x
    Google Scholar
  • 11 Carey RM, Godovchik J, Workman AD. et al. Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma. Int Forum Allergy Rhinol 2017; 7 (12) 1186-1194
    CrossrefPubMedGoogle Scholar
  • 12 Carey RM, Parasher AK, Workman AD. et al. Disparities in sinonasal squamous cell carcinoma short- and long-term outcomes: analysis from the national cancer database. Laryngoscope 2018; 128 (03) 560-567
    CrossrefPubMedGoogle Scholar
  • 13 Carey RM, Fathy R, Shah RR. et al. Association of type of treatment facility with overall survival after a diagnosis of head and neck cancer. JAMA Netw Open 2020; 3 (01) e1919697
    CrossrefPubMedGoogle Scholar
  • 14 Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 1997; 174 (05) 495-498
    CrossrefPubMedGoogle Scholar
  • 15 Rhee CS, Won TB, Lee CH. et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope 2006; 116 (06) 982-986
    CrossrefPubMedGoogle Scholar
  • 16 Hayashi T, Nonaka S, Bandoh N, Kobayashi Y, Imada M, Harabuchi Y. Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer 2001; 92 (06) 1495-1503
    CrossrefPubMedGoogle Scholar
  • 17 Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1977; 40 (01) 145-151
    CrossrefPubMedGoogle Scholar
  • 18 Kim BS, Vongtama R, Juillard G. Sinonasal undifferentiated carcinoma: case series and literature review. Am J Otolaryngol 2004; 25 (03) 162-166
    CrossrefPubMedGoogle Scholar
  • 19 Lin EM, Sparano A, Spalding A. et al. Sinonasal undifferentiated carcinoma: a 13-year experience at a single institution. Skull Base 2010; 20 (02) 61-67
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Musy PY, Reibel JF, Levine PA. Sinonasal undifferentiated carcinoma: the search for a better outcome. Laryngoscope 2002; 112 (8 Pt 1): 1450-1455
    CrossrefPubMedGoogle Scholar
  • 21 Roth TN, Gengler C, Huber GF, Holzmann D. Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 2010; 32 (10) 1385-1392
    CrossrefPubMedGoogle Scholar
  • 22 Cheng Y-F, Lai C-C, Ho C-Y, Shu C-H, Lin C-Z. Toward a better understanding of sinonasal mucosal melanoma: clinical review of 23 cases. J Chin Med Assoc 2007; 70 (01) 24-29
    CrossrefPubMedGoogle Scholar
  • 23 Bartell HL, Bedikian AY, Papadopoulos NE. et al. Biochemotherapy in patients with advanced head and neck mucosal melanoma. Head Neck 2008; 30 (12) 1592-1598
    CrossrefPubMedGoogle Scholar
  • 24 Gavriel H, McArthur G, Sizeland A, Henderson M. Review: mucosal melanoma of the head and neck. Melanoma Res 2011; 21 (04) 257-266
    CrossrefPubMedGoogle Scholar
  • 25 Wu S-G, Zhang W-W, Sun J-Y, Li FY, Lin Q, He ZY. Patterns of distant metastasis between histological types in esophageal cancer. Front Oncol 2018; 8: 302
    CrossrefPubMedGoogle Scholar
  • 26 Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML. Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol 2008; 179 (02) 474-477
    CrossrefPubMedGoogle Scholar
  • 27 Gerratana L, Fanotto V, Bonotto M. et al. Pattern of metastasis and outcome in patients with breast cancer. Clin Exp Metastasis 2015; 32 (02) 125-133
    CrossrefPubMedGoogle Scholar
  • 28 Sihto H, Lundin J, Lundin M. et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res 2011; 13 (05) R87
    CrossrefPubMedGoogle Scholar
  • 29 Wu Q, Li J, Zhu S. et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget 2017; 8 (17) 27990-27996
    CrossrefPubMedGoogle Scholar
  • 30 Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007; 110 (07) 1451-1456
    CrossrefPubMedGoogle Scholar
  • 31 Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck 2012; 34 (06) 877-885
    CrossrefPubMedGoogle Scholar
  • 32 Bhattacharyya N. Cancer of the nasal cavity: survival and factors influencing prognosis. Arch Otolaryngol Head Neck Surg 2002; 128 (09) 1079-1083
    CrossrefPubMedGoogle Scholar
  • 33 Trope M, Triantafillou V, Kohanski MA. et al. Adenoid cystic carcinoma of the sinonasal tract: a review of the national cancer database. Paper presented at: International forum of allergy & rhinology. Accessed 2019 at: https://onlinelibrary.wiley.com/doi/abs/10.1002/alr.22255
    PubMedGoogle Scholar
  • 34 Khademi B, Moradi A, Hoseini S, Mohammadianpanah M. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg 2009; 13 (04) 191-199
    CrossrefPubMedGoogle Scholar
  • 35 Jakobsen MH, Larsen SK, Kirkegaard J, Hansen HS. Cancer of the nasal cavity and paranasal sinuses. Prognosis and outcome of treatment. Acta Oncol 1997; 36 (01) 27-31
    CrossrefPubMedGoogle Scholar
  • 36 Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92 (12) 3012-3029
    CrossrefPubMedGoogle Scholar
  • 37 McKay SP, Shibuya TY, Armstrong WB. et al. Cell carcinoma of the paranasal sinuses and skull base. Am J Otolaryngol 2007; 28 (05) 294-301
    CrossrefPubMedGoogle Scholar
  • 38 Desai PB, Bukatko AR, Simpson MC. et al. Comorbidity burden and nonclinical factors associated with sinonasal cancer all-cause mortality. Laryngoscope 2020; 130 (06) 1443-1449
    CrossrefPubMedGoogle Scholar
  • 39 Kuo P, Manes RP, Schwam ZG, Judson BL. Survival outcomes for combined modality therapy for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg 2017; 156 (01) 132-136
    CrossrefPubMedGoogle Scholar
  • 40 Bhattacharyya N. Factors affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg 2003; 61 (09) 1016-1021
    CrossrefPubMedGoogle Scholar
  • 41 Agarwal P, Jones EA, Devaiah AK. Education and insurance status: Impact on treatment and survival of sinonasal cancer patients. Laryngoscope 2020; 130 (03) 649-658
    CrossrefPubMedGoogle Scholar
  • 42 2020 Standards and Resources. American College of Surgeons. Accessed July 24, 2020 at: https://www.facs.org/quality-programs/cancer/coc/standards/2020
    PubMedGoogle Scholar
  • 43 Mohanty S, Bilimoria KY. Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program. J Surg Oncol 2014; 109 (07) 629-630
    CrossrefPubMedGoogle Scholar